437 related articles for article (PubMed ID: 12825236)
21. B cell apoptosis accelerates the onset of murine lupus.
Trébéden-Nègre H; Weill B; Fournier C; Batteux F
Eur J Immunol; 2003 Jun; 33(6):1603-12. PubMed ID: 12778478
[TBL] [Abstract][Full Text] [Related]
22. T cell cytokine imbalance towards production of IFN-gamma and IL-10 in NZB/W F1 lupus-prone mice is associated with autoantibody levels and nephritis.
Enghard P; Langnickel D; Riemekasten G
Scand J Rheumatol; 2006; 35(3):209-16. PubMed ID: 16766368
[TBL] [Abstract][Full Text] [Related]
23. Glatiramer acetate treatment does not modify the clinical course of (NZB x BXSB)F1 lupus murine model.
Borel P; Benkhoucha M; Weber MS; Zamvil SS; Santiago-Raber ML; Lalive PH
Int Immunol; 2008 Oct; 20(10):1313-9. PubMed ID: 18687587
[TBL] [Abstract][Full Text] [Related]
24. Lupus-like syndrome in some strains of nude mice.
Monier JC; Costa O; Souweine G; Rigal D
Thymus; 1980 Jan; 1(4-5):241-55. PubMed ID: 6969475
[TBL] [Abstract][Full Text] [Related]
25. Effects of parturition, suckling and pseudopregnancy on variables of disease activity in the B/W mouse model of systemic lupus erythematosus.
McMurray RW; Keisler D; Izui S; Walker SE
J Rheumatol; 1993 Jul; 20(7):1143-51. PubMed ID: 8371207
[TBL] [Abstract][Full Text] [Related]
26. Production of high affinity autoantibodies in autoimmune New Zealand Black/New Zealand white F1 mice targeted with an anti-DNA heavy chain.
Friedmann D; Yachimovich N; Mostoslavsky G; Pewzner-Jung Y; Ben-Yehuda A; Rajewsky K; Eilat D
J Immunol; 1999 Apr; 162(8):4406-16. PubMed ID: 10201976
[TBL] [Abstract][Full Text] [Related]
27. Resistance to tolerance induction is not prerequisite to development of murine SLE.
Izui S; Masuda K
J Immunol; 1984 Dec; 133(6):3010-4. PubMed ID: 6491280
[TBL] [Abstract][Full Text] [Related]
28. Genetics of systemic autoimmunity in mouse models of lupus.
Kono DH; Theofilopoulos AN
Int Rev Immunol; 2000; 19(4-5):367-87. PubMed ID: 11016424
[TBL] [Abstract][Full Text] [Related]
29. The lupus phenotype in B6.NZBc1 congenic mice reflects interactions between multiple susceptibility loci and a suppressor locus.
Cheung YH; Landolt-Marticorena C; Lajoie G; Wither JE
Genes Immun; 2011 Jun; 12(4):251-62. PubMed ID: 21307879
[TBL] [Abstract][Full Text] [Related]
30. Analysis of MHC class II genes in the susceptibility to lupus in New Zealand mice.
Rozzo SJ; Vyse TJ; David CS; Palmer E; Izui S; Kotzin BL
J Immunol; 1999 Mar; 162(5):2623-30. PubMed ID: 10072504
[TBL] [Abstract][Full Text] [Related]
31. Transgenic overexpression of anti-double-stranded DNA autoantibody and activation of Toll-like receptor 4 in mice induce severe systemic lupus erythematosus syndromes.
Lee TP; Tang SJ; Wu MF; Song YC; Yu CL; Sun KH
J Autoimmun; 2010 Dec; 35(4):358-67. PubMed ID: 20833510
[TBL] [Abstract][Full Text] [Related]
32. Systemic lupus erythematosus-related autoantibody production in mice is determined by bone marrow-derived cells.
Levite M; Zinger H; Mozes E; Reisner Y
Bone Marrow Transplant; 1993 Sep; 12(3):179-83. PubMed ID: 8241973
[TBL] [Abstract][Full Text] [Related]
33. Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fc gamma receptor II (CD32).
Werwitzke S; Trick D; Sondermann P; Kamino K; Schlegelberger B; Kniesch K; Tiede A; Jacob U; Schmidt RE; Witte T
Ann Rheum Dis; 2008 Feb; 67(2):154-61. PubMed ID: 17557887
[TBL] [Abstract][Full Text] [Related]
34. IL-4Ralpha polymorphism in regulation of IL-4 synthesis by T cells: implication in susceptibility to a subset of murine lupus.
Shiroiwa W; Tsukamoto K; Ohtsuji M; Lin Q; Ida A; Kodera S; Ohtsuji N; Nakamura K; Tsurui H; Kinoshita K; Nishimura H; Shirai T; Hirose S
Int Immunol; 2007 Feb; 19(2):175-83. PubMed ID: 17189592
[TBL] [Abstract][Full Text] [Related]
35. Autoimmunity develops in lupus-prone NZB mice despite normal T cell tolerance.
Wither J; Vukusic B
J Immunol; 1998 Nov; 161(9):4555-62. PubMed ID: 9794382
[TBL] [Abstract][Full Text] [Related]
36. Systemic autoimmune disease induced by dendritic cells that have captured necrotic but not apoptotic cells in susceptible mouse strains.
Ma L; Chan KW; Trendell-Smith NJ; Wu A; Tian L; Lam AC; Chan AK; Lo CK; Chik S; Ko KH; To CK; Kam SK; Li XS; Yang CH; Leung SY; Ng MH; Stott DI; MacPherson GG; Huang FP
Eur J Immunol; 2005 Nov; 35(11):3364-75. PubMed ID: 16224814
[TBL] [Abstract][Full Text] [Related]
37. Comparison of chlordecone effects on autoimmunity in (NZBxNZW) F(1) and BALB/c mice.
Sobel ES; Wang F; Butfiloski E; Croker B; Roberts SM
Toxicology; 2006 Feb; 218(2-3):81-9. PubMed ID: 16309813
[TBL] [Abstract][Full Text] [Related]
38. On the biological origin of anti-double-stranded (ds) DNA antibodies: systemic lupus erythematosus-related anti-dsDNA antibodies are induced by polyomavirus BK in lupus-prone (NZBxNZW) F1 hybrids, but not in normal mice.
Fredriksen K; Osei A; Sundsfjord A; Traavik T; Rekvig OP
Eur J Immunol; 1994 Jan; 24(1):66-70. PubMed ID: 8020573
[TBL] [Abstract][Full Text] [Related]
39. Decrease in glomerulonephritis and Th1-associated autoantibody production after progesterone treatment in NZB/NZW mice.
Hughes GC; Martin D; Zhang K; Hudkins KL; Alpers CE; Clark EA; Elkon KB
Arthritis Rheum; 2009 Jun; 60(6):1775-84. PubMed ID: 19479860
[TBL] [Abstract][Full Text] [Related]
40. Silica accelerated systemic autoimmune disease in lupus-prone New Zealand mixed mice.
Brown JM; Archer AJ; Pfau JC; Holian A
Clin Exp Immunol; 2003 Mar; 131(3):415-21. PubMed ID: 12605693
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
